Trial intelligence / Profile preview

Prolotherapy for knee osteoarthritis

RBR-59ytd4cPhase 4Completed

Sponsor
Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
Start
Mar 2024
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dextrose and hyaluronic acid in knee osteoarthritis (OA) (3 arms), sponsored by Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad. Started Mar 2024; status: completed.

02

Drugs

dextrosehyaluronic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on RBR-59ytd4c.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-59ytd4c.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call